Equity

Total Equity

Medtronic Total Equity increased by 0.7% to $48.99B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from $49.39B to $48.99B. Over 4 years (FY 2021 to FY 2025), Total Equity shows relatively stable performance with a -1.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2013
Last reportedQ3 2026Feb 24, 2026

How to read this metric

An increase generally signals growth in retained earnings or capital injections, while a decrease may indicate share buybacks, dividend payments, or net losses.

Detailed definition

This represents the residual interest in the assets of the entity after deducting all its liabilities. It reflects the n...

Peer comparison

Standard across all public companies; peers in the medical device and diagnostics sector typically maintain high equity levels to support R&D and M&A.

Metric ID: total_stockholders_equity

Historical Data

20 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Value$51.43B$51.49B$51.99B$52.54B$52.55B$52.67B$51.88B$51.44B$51.48B$51.18B$51.46B$51.79B$50.21B$47.95B$48.49B$49.39B$48.02B$47.89B$48.65B$48.99B
QoQ Change+0.1%+1.0%+1.1%+0.0%+0.2%-1.5%-0.8%+0.1%-0.6%+0.6%+0.6%-3.0%-4.5%+1.1%+1.8%-2.8%-0.3%+1.6%+0.7%
YoY Change+2.2%+2.3%-0.2%-2.1%-2.0%-2.8%-0.8%+0.7%-2.5%-6.3%-5.8%-4.6%-4.4%-0.1%+0.3%-0.8%
Range$47.89B$52.67B
CAGR-1.0%
Avg YoY Growth-1.7%
Median YoY Growth-1.4%
Current Streak2 quarters growth

Frequently Asked Questions

What is Medtronic's total equity?
Medtronic (MDT) reported total equity of $48.99B in Q4 2025.
How has Medtronic's total equity changed year-over-year?
Medtronic's total equity decreased by 0.8% year-over-year, from $49.39B to $48.99B.
What is the long-term trend for Medtronic's total equity?
Over 4 years (2021 to 2025), Medtronic's total equity has grown at a -1.7% compound annual growth rate (CAGR), from $51.43B to $48.02B.
What does total equity mean?
The total value of the company that belongs to the shareholders after all debts are paid.